Impact of COVID-19 on MedTech Regulatory Bodies & Health Agencies

Impact of COVID-19 on MedTech Regulatory Bodies & Health Agencies

The COVID-19 pandemic has thrust the medical device industry into an unprecedented situation, forcing medical regulatory bodies and health agencies to enact extraordinary measures in order to ensure a strong response to local COVID-19 transmission while maintaining the continuity of health care services in a safe and efficient manner.

In addition to highlighting current and anticipated challenges and considering the long-term impact of the COVID-19 pandemic, this E-Book outlines how regulators and agencies in the US, Europe, and the Asia Pacific region are adapting to the situation, particularly in order to:

  • Mitigate infection risks,
  • Facilitate access to essential medical products,
  • Remove undue regulatory burdens,
  • Support affected economic operators, and
  • Improve digital health capabilities

Logo